DK1109534T3 - Farmaceutiske præparater med quick release af den aktive substans - Google Patents
Farmaceutiske præparater med quick release af den aktive substansInfo
- Publication number
- DK1109534T3 DK1109534T3 DK99941418T DK99941418T DK1109534T3 DK 1109534 T3 DK1109534 T3 DK 1109534T3 DK 99941418 T DK99941418 T DK 99941418T DK 99941418 T DK99941418 T DK 99941418T DK 1109534 T3 DK1109534 T3 DK 1109534T3
- Authority
- DK
- Denmark
- Prior art keywords
- active substance
- composition
- powder
- sieve
- therapeutically
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA199801143 | 1998-09-10 | ||
PCT/DK1999/000480 WO2000015195A1 (en) | 1998-09-10 | 1999-09-10 | Quick release pharmaceutical compositions of drug substances |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1109534T3 true DK1109534T3 (da) | 2003-06-10 |
Family
ID=8101500
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99941418T DK1109534T3 (da) | 1998-09-10 | 1999-09-10 | Farmaceutiske præparater med quick release af den aktive substans |
Country Status (13)
Country | Link |
---|---|
US (1) | US6713089B1 (ja) |
EP (1) | EP1109534B1 (ja) |
JP (2) | JP5026635B2 (ja) |
AT (1) | ATE232382T1 (ja) |
AU (1) | AU5504599A (ja) |
CA (1) | CA2343148C (ja) |
DE (1) | DE69905380T2 (ja) |
DK (1) | DK1109534T3 (ja) |
EA (1) | EA004032B1 (ja) |
ES (1) | ES2190241T3 (ja) |
PT (1) | PT1109534E (ja) |
TR (1) | TR200100708T2 (ja) |
WO (1) | WO2000015195A1 (ja) |
Families Citing this family (81)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US8231899B2 (en) * | 1998-09-10 | 2012-07-31 | Nycomed Danmark Aps | Quick release pharmaceutical compositions of drug substances |
SA99191255B1 (ar) | 1998-11-30 | 2006-11-25 | جي دي سيرل اند كو | مركبات سيليكوكسيب celecoxib |
US20020035107A1 (en) | 2000-06-20 | 2002-03-21 | Stefan Henke | Highly concentrated stable meloxicam solutions |
EP1250921A1 (en) * | 2001-04-21 | 2002-10-23 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Fast disintegrating meloxicam tablet |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
DE10161077A1 (de) | 2001-12-12 | 2003-06-18 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion |
US20030161875A1 (en) * | 2002-02-27 | 2003-08-28 | Deepak Murpani | Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors |
US8992980B2 (en) | 2002-10-25 | 2015-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Water-soluble meloxicam granules |
US20040109889A1 (en) * | 2002-12-04 | 2004-06-10 | Bunick Frank J. | Surface treatment composition for soft substrates |
US20040202717A1 (en) | 2003-04-08 | 2004-10-14 | Mehta Atul M. | Abuse-resistant oral dosage forms and method of use thereof |
WO2005004915A2 (en) * | 2003-07-09 | 2005-01-20 | Boehringer Ingelheim International Gmbh | Compositions comprising meloxicam |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
EP1568369A1 (en) | 2004-02-23 | 2005-08-31 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the treatment of respiratory diseases in pigs |
US20050220877A1 (en) * | 2004-03-31 | 2005-10-06 | Patel Ashish A | Bilayer tablet comprising an antihistamine and a decongestant |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
JP5438898B2 (ja) * | 2004-06-29 | 2014-03-12 | タケダ ファーマ アクティーゼルスカブ | 水不溶性薬剤の速放性医薬組成物の製造と、本発明の方法で得られた医薬組成物 |
JP5490347B2 (ja) * | 2005-05-27 | 2014-05-14 | エスエス製薬株式会社 | 経口投与用製剤 |
JO3352B1 (ar) | 2005-06-17 | 2019-03-13 | Apr Applied Pharma Res Sa | صيغ دايكلوفيناك وطرق استخدامه |
MX2008000967A (es) | 2005-07-20 | 2008-03-26 | Panacea Biotec Ltd | Nueva composicion farmaceutica de forma de dosis de liberacion modificada que comprende inhibidor de enzima ciclooxigenasa. |
EP1909777A2 (en) * | 2005-07-22 | 2008-04-16 | Myriad Genetics, Inc. | High drug load formulations and dosage forms |
EP3838903B1 (en) | 2005-12-13 | 2023-11-22 | Incyte Holdings Corporation | Pyrrolo[2,3-d]pyrimidine derivative as janus kinase inhibitor |
US20070154542A1 (en) * | 2005-12-30 | 2007-07-05 | Cogentus Pharmaceuticals, Inc. | Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors |
CA2661818A1 (en) * | 2006-05-03 | 2007-11-15 | Kowa Pharmaceuticals America, Inc. | Acute pain medications based on fast acting diclofenac-opioid combinations |
EP2043613A1 (en) * | 2006-07-14 | 2009-04-08 | Fmc Corporation | Solid form |
WO2008062449A2 (en) * | 2006-09-18 | 2008-05-29 | Glenmark Pharmaceuticals Limited | A novel pharmaceutical soft gel composition containing dexibuprofen and paracetamol |
US20080081067A1 (en) * | 2006-10-03 | 2008-04-03 | Gupta Manishkumar | Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof |
US20080311162A1 (en) * | 2007-05-16 | 2008-12-18 | Olivia Darmuzey | Solid form |
ES2467665T5 (es) | 2007-06-13 | 2022-11-03 | Incyte Holdings Corp | Sales del inhibidor de cinasas Janus (R)-3-(4-(7H-pirrolo[2,3-d]pirimidin-4-il)-1H-pirazol-1-il)-3-ciclopentilpropanonitrilo |
EP2471517A3 (en) | 2007-09-14 | 2012-12-26 | Wockhardt Limited | Rhein or diacerein compositions |
EP3090739A1 (en) | 2008-01-04 | 2016-11-09 | Schabar Research Associates LLC | Compositions composed of naproxen sodium and nizatidine |
RU2010151952A (ru) * | 2008-05-20 | 2012-06-27 | Ньюроджесэкс, Инк. (Us) | Водорастворимые аналоги ацетаминофена |
CA2724881C (en) | 2008-05-20 | 2016-09-27 | Neurogesx, Inc. | Carbonate prodrugs and methods of using the same |
CN102209529A (zh) | 2008-09-09 | 2011-10-05 | 阿斯利康(瑞典)有限公司 | 将药物组合物递送至有需要的患者的方法 |
AU2010249443B2 (en) | 2009-05-22 | 2015-08-13 | Incyte Holdings Corporation | 3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]octane- or heptane-nitrile as JAK inhibitors |
CA2766524A1 (en) * | 2009-06-25 | 2010-12-29 | Pozen Inc. | Method for treating a patient in need of aspirin therapy |
EP2445499A4 (en) | 2009-06-25 | 2013-02-27 | Astrazeneca Ab | METHOD FOR TREATING A PATIENT WITH RISK OF DEVELOPING A NSAID-ASSOCIATED SPURGE |
TW201113285A (en) * | 2009-09-01 | 2011-04-16 | Incyte Corp | Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors |
IN2012DN03157A (ja) | 2009-10-12 | 2015-09-18 | Boehringer Ingelheim Vetmed | |
WO2011107150A1 (en) | 2010-03-03 | 2011-09-09 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats |
PH12015502575A1 (en) | 2010-03-10 | 2017-04-24 | Incyte Corp | Piperidin-4-yl azetidine derivatives as jak1 inhibitors |
US9795568B2 (en) | 2010-05-05 | 2017-10-24 | Boehringer Ingelheim Vetmedica Gmbh | Low concentration meloxicam tablets |
DK2574168T3 (en) | 2010-05-21 | 2016-05-09 | Incyte Holdings Corp | Topical formulation to a jak inhibitor |
EP2394641A1 (en) | 2010-05-30 | 2011-12-14 | Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi | Pharmaceutical formulations of lornoxicam |
CA2818542A1 (en) | 2010-11-19 | 2012-05-24 | Incyte Corporation | Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors |
JP5917544B2 (ja) | 2010-11-19 | 2016-05-18 | インサイト・ホールディングス・コーポレイションIncyte Holdings Corporation | Jak阻害剤としての複素環置換ピロロピリジンおよびピロロピリミジン |
WO2012146314A1 (en) | 2011-04-29 | 2012-11-01 | Refarmed Chemicals Sa | Thin gelatin capsules for rapid drug release in the mouth |
CA2839767A1 (en) | 2011-06-20 | 2012-12-27 | Incyte Corporation | Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors |
TW201313721A (zh) | 2011-08-18 | 2013-04-01 | Incyte Corp | 作為jak抑制劑之環己基氮雜環丁烷衍生物 |
UA111854C2 (uk) | 2011-09-07 | 2016-06-24 | Інсайт Холдінгс Корпорейшн | Способи і проміжні сполуки для отримання інгібіторів jak |
JP2012012411A (ja) * | 2011-10-03 | 2012-01-19 | Ssp Co Ltd | 経口投与用製剤 |
WO2013101897A2 (en) | 2011-12-28 | 2013-07-04 | Pozen Inc. | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid |
PL2838516T3 (pl) | 2012-04-18 | 2019-05-31 | SpecGx LLC | Zapobiegające nadużywaniu kompozycje farmaceutyczne o natychmiastowym uwalnianiu |
US9855286B2 (en) | 2012-05-18 | 2018-01-02 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component |
US9320729B2 (en) | 2012-05-18 | 2016-04-26 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative |
US20130310385A1 (en) | 2012-05-18 | 2013-11-21 | Gruenenthal Gmbh | Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants |
US9308196B2 (en) * | 2012-05-18 | 2016-04-12 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1 r,4r) -6'-fluoro-N ,N-dimethyl-4-phenyl-4',9'-d ihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and an oxicam |
US20130310435A1 (en) | 2012-05-18 | 2013-11-21 | Gruenenthal Gmbh | Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol |
AR091079A1 (es) | 2012-05-18 | 2014-12-30 | Incyte Corp | Derivados de pirrolopirimidina y pirrolopiridina sustituida con piperidinilciclobutilo como inhibidores de jak |
ES2880814T3 (es) | 2012-11-15 | 2021-11-25 | Incyte Holdings Corp | Formas de dosificación de liberación sostenida de ruxolitinib |
CR20190518A (es) | 2013-03-06 | 2020-01-10 | Incyte Corp | PROCESOS E INTERMEDIOS PARA HACER UN INHIBIDOR DE JAK (Divisional 2015-0471) |
JP6255474B2 (ja) | 2013-03-15 | 2017-12-27 | マリンクロッド エルエルシー | 機能的割線を有する即時放出用の乱用抑止性固体剤形 |
JP2013216701A (ja) * | 2013-07-29 | 2013-10-24 | Ssp Co Ltd | 経口投与用製剤 |
JP6304896B2 (ja) * | 2013-07-30 | 2018-04-04 | ライオン株式会社 | 錠剤 |
TWI822248B (zh) | 2013-08-07 | 2023-11-11 | 美商英塞特控股公司 | Jak1抑制劑之持續釋放劑型 |
WO2015184305A1 (en) | 2014-05-30 | 2015-12-03 | Incyte Corporation | TREATMENT OF CHRONIC NEUTROPHILIC LEUKEMIA (CNL) AND ATYPICAL CHRONIC MYELOID LEUKEMIA (aCML) BY INHIBITORS OF JAK1 |
AU2015284078B2 (en) | 2014-07-03 | 2020-01-30 | SpecGx LLC | Abuse deterrent immediate release formulations comprising non-cellulose polysaccharides |
WO2017048720A1 (en) | 2015-09-15 | 2017-03-23 | Praxis Biosciences, Llc | Prodrugs of fencamfamine |
WO2018197932A1 (en) | 2017-04-27 | 2018-11-01 | Dr. Reddy's Laboratories Ltd. | Pharmaceutical compositions of ketorolac |
AR113922A1 (es) | 2017-12-08 | 2020-07-01 | Incyte Corp | Terapia de combinación de dosis baja para el tratamiento de neoplasias mieloproliferativas |
BR112020015470A2 (pt) | 2018-01-30 | 2020-12-08 | Incyte Corporation | Processos para preparação de (1-(3-fluoro-2-(trifluorometil)isonicotinil)piperidina-4-ona |
UA127925C2 (uk) | 2018-03-30 | 2024-02-14 | Інсайт Корпорейшн | Лікування гнійного гідраденіту з використанням інгібіторів jak |
JP7170437B2 (ja) * | 2018-06-29 | 2022-11-14 | 小林製薬株式会社 | 内服用医薬組成物 |
WO2020068510A1 (en) | 2018-09-25 | 2020-04-02 | SpecGx LLC | Abuse deterrent immediate release capsule dosage forms |
US11779541B2 (en) * | 2019-03-26 | 2023-10-10 | Johnson & Johnson Consumer Inc. | Immediate release dosage form |
TW202131926A (zh) | 2019-11-22 | 2021-09-01 | 美商英塞特公司 | 包含alk2抑制劑及jak2抑制劑的組合療法 |
JP7499025B2 (ja) | 2019-12-27 | 2024-06-13 | 小林製薬株式会社 | 内服用医薬組成物 |
US11833155B2 (en) | 2020-06-03 | 2023-12-05 | Incyte Corporation | Combination therapy for treatment of myeloproliferative neoplasms |
WO2022015784A1 (en) | 2020-07-15 | 2022-01-20 | Schabar Research Associates Llc | Unit oral dose compositions composed of ibuprofen and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburn |
CA3124579A1 (en) | 2020-07-15 | 2022-01-15 | Schabar Research Associates Llc | Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4965072A (en) * | 1988-11-03 | 1990-10-23 | Miles Inc. | Granulating composition and method |
US5219574A (en) * | 1989-09-15 | 1993-06-15 | Cima Labs. Inc. | Magnesium carbonate and oil tableting aid and flavoring additive |
JP2906528B2 (ja) * | 1990-02-14 | 1999-06-21 | 大正製薬株式会社 | 吸収を促進した内服用固形製剤 |
CA2061520C (en) * | 1991-03-27 | 2003-04-22 | Lawrence J. Daher | Delivery system for enhanced onset and increased potency |
ATE216577T1 (de) * | 1992-01-29 | 2002-05-15 | Takeda Chemical Industries Ltd | Schnellösliche tablette und ihre herstellung |
WO1995032737A1 (en) | 1994-05-27 | 1995-12-07 | Farmarc Nederland Bv | Pharmaceutical composition |
ZA959469B (en) | 1994-11-15 | 1996-05-15 | South African Druggists Ltd | Pharmaceutical composition |
-
1999
- 1999-09-10 TR TR2001/00708T patent/TR200100708T2/xx unknown
- 1999-09-10 ES ES99941418T patent/ES2190241T3/es not_active Expired - Lifetime
- 1999-09-10 DE DE69905380T patent/DE69905380T2/de not_active Expired - Lifetime
- 1999-09-10 WO PCT/DK1999/000480 patent/WO2000015195A1/en active IP Right Grant
- 1999-09-10 PT PT99941418T patent/PT1109534E/pt unknown
- 1999-09-10 CA CA002343148A patent/CA2343148C/en not_active Expired - Lifetime
- 1999-09-10 AT AT99941418T patent/ATE232382T1/de active
- 1999-09-10 EP EP99941418A patent/EP1109534B1/en not_active Expired - Lifetime
- 1999-09-10 EA EA200100331A patent/EA004032B1/ru not_active IP Right Cessation
- 1999-09-10 JP JP2000569779A patent/JP5026635B2/ja not_active Expired - Lifetime
- 1999-09-10 US US09/786,864 patent/US6713089B1/en not_active Expired - Lifetime
- 1999-09-10 AU AU55045/99A patent/AU5504599A/en not_active Abandoned
- 1999-09-10 DK DK99941418T patent/DK1109534T3/da active
-
2011
- 2011-10-14 JP JP2011227314A patent/JP5622703B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP5026635B2 (ja) | 2012-09-12 |
TR200100708T2 (tr) | 2001-07-23 |
CA2343148A1 (en) | 2000-03-23 |
JP2012082197A (ja) | 2012-04-26 |
DE69905380T2 (de) | 2003-11-27 |
JP2002524492A (ja) | 2002-08-06 |
CA2343148C (en) | 2005-11-15 |
EP1109534A1 (en) | 2001-06-27 |
WO2000015195A1 (en) | 2000-03-23 |
EP1109534B1 (en) | 2003-02-12 |
DE69905380D1 (de) | 2003-03-20 |
JP5622703B2 (ja) | 2014-11-12 |
EA200100331A1 (ru) | 2001-08-27 |
ES2190241T3 (es) | 2003-07-16 |
EA004032B1 (ru) | 2003-12-25 |
US6713089B1 (en) | 2004-03-30 |
ATE232382T1 (de) | 2003-02-15 |
PT1109534E (pt) | 2003-06-30 |
AU5504599A (en) | 2000-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1109534T3 (da) | Farmaceutiske præparater med quick release af den aktive substans | |
DE69934135D1 (de) | Dosierungsformen enthaltend geschmacksmaskierten wirkstoffen | |
EA200601588A1 (ru) | Стабилизированные перенасыщенные твёрдые растворы липофильных лекарственных средств | |
DK1441704T3 (da) | Orodispersibel tablet med höj homogenitet og fremgangsmåde til fremstilling heraf | |
EE03902B1 (et) | Osakesed, nende valmistamismeetod ja kasutamine, farmatseutiline doseerimisvorm ja selle valmistamismeetod, tahke dispersioon ning farmatseutiline pakend | |
HUP0000116A2 (hu) | Íz-maszkírozott mikrokapszulás készítmények és a gyártásukra szolgáló eljárások | |
SK5672001A3 (en) | Improved fast disintegrating tablet | |
WO2002043702A3 (en) | Pharmaceutical compositions for inhalation | |
ATE164060T1 (de) | Inhalationspulver und verfahren zu ihrer herstellung | |
UA41346C2 (uk) | Фармацевтична композиція, яка містить флуоксетин або його сіль, таблетка на її основі, спосіб виробництва таблетки, яка диспергується | |
KR960021061A (ko) | 경구 투여용 약제학적 조성물 | |
EE200000186A (et) | Osake, selliste osakeste valmistamismeetod ja kasutamine, farmatseutiline doosivorm ja selle valmistamismeetod, tahke dispersioon ja farmatseutiline pakend | |
EE200100104A (et) | 5-HT4 agonisti või antagonisti uus peroraalne ravimvorm | |
Zimm et al. | Drug release from a multiparticulate pellet system | |
DE69836678D1 (de) | Chinolin- und chinazolinderivate als antagonisten des corticotropin freisetzenden faktors (crf) | |
RU97111870A (ru) | Фармацевтический состав, содержащий ламотригин | |
SK16892000A3 (sk) | Farmaceutický prostriedok obsahujúci levotyroxín nátrium a spôsob jeho výroby | |
TR200504890T1 (tr) | Benipidin hidroklorür içeren farmasötik bileşim | |
DE69408122T2 (de) | Zusammensetzung aus mikropartikeln in verdichteter phase und verfahren | |
CY1113221T1 (el) | Διεργασια για την παρασκευη ενος φαρμακου | |
WO2003028624A3 (en) | Levothyroxine compositions and methods | |
JP2000319177A (ja) | ストレス改善剤 | |
JP2789115B2 (ja) | 可溶性コラーゲンパウダーを担体とする粒状医薬徐放剤の製造方法 | |
JP3796848B2 (ja) | 生薬類配合固形組成物 | |
HUP0100398A2 (hu) | Eljárás gyógyászati készítmény előállítására |